Literature DB >> 11444578

Assessment of hypercholesterolemia control in a managed care organization.

R J Straka1, R Taheri, S L Cooper, A W Tan, A C Smith.   

Abstract

To determine the extent of achievement of goal low-density lipoprotein cholesterol (LDL) as defined by National Cholesterol Education Program-Adult Treatment Panel II (NCEP-ATP 11) and American Diabetes Association (ADA) 2000 guidelines, we conducted a retrospective study by integrating data from medical, laboratory, and pharmacy claims databases. Subjects were selected from a 232,000-member staff-model managed care organization consisting of 19 clinics in the Minneapolis-St. Paul, Minnesota, metropolitan area. A total of 124,971 members aged 18 years and older, who had been continuously enrolled from July 1, 1996-June 6, 1998, were included. Outcome measures were the extent of achievement of goal LDL as defined by NCEP-ATP II and the use of antihyperlipidemic drugs for patients with and without diabetes at various levels of risk for coronary heart disease (CHD). Of 124,971 subjects, 6538 had a history of CHD, 1523 of whom met their LDL goal. Of the population with CHD who did not achieve goal, 1141 (43%) missed by over 30 mg/dl; 621 (54%) of these patients were not receiving drug therapy A total of 17,267 had no history of CHD but had two or more risk factors; 3,298 of these achieved their LDL goal. Of those who did not achieve goal, 1,136 (35%) missed by over 30 mg/dl; 897 (79%) of these were not receiving drug therapy A total of 6,586 had a history of diabetes; 1,004 and 2,340 reached an LDL of 100 mg/dl or lower and less than 130 mg/dl, respectively Of those with diabetes who had an LDL greater than 100 mg/dl, 1,276 (49%) missed their goal by over 30 mg/dl; 898 (70%) of these were not receiving drug therapy. Inadequate use of pharmacologic agents plays a significant role in failure to achieve goal LDL for patients with CHD, without CHD, and with diabetes. Analysis of the data based on the new ADA guidelines for LDL demonstrates the need for continued vigilance. Finally, the successful merging of medical, laboratory, and pharmacy claims databases provides a benchmark for other institutions.

Entities:  

Mesh:

Year:  2001        PMID: 11444578     DOI: 10.1592/phco.21.9.818.34563

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  7 in total

1.  Missed opportunities in diabetes management: a longitudinal assessment of factors associated with sub-optimal quality.

Authors:  T Alafia Samuels; Shari Bolen; H C Yeh; Marcela Abuid; Spyridon S Marinopoulos; Jonathan P Weiner; Maura McGuire; Frederick L Brancati
Journal:  J Gen Intern Med       Date:  2008-09-12       Impact factor: 5.128

Review 2.  Optimizing lipid lowering in patients at risk.

Authors:  Luther T Clark
Journal:  Clin Cardiol       Date:  2004-06       Impact factor: 2.882

3.  Appropriateness of cholesterol management in primary care by sex and level of cardiovascular risk.

Authors:  Ann Hiott Barham; David C Goff; Haiying Chen; Aarthi Balasubramanyam; Erica Rosenberger; Denise E Bonds; Alain G Bertoni
Journal:  Prev Cardiol       Date:  2009

4.  Impact of a multifaceted intervention on cholesterol management in primary care practices: guideline adherence for heart health randomized trial.

Authors:  Alain G Bertoni; Denise E Bonds; Haiying Chen; Patricia Hogan; Lenore Crago; Erica Rosenberger; Ann Hiott Barham; C Randall Clinch; David C Goff
Journal:  Arch Intern Med       Date:  2009-04-13

5.  Adherence to lipid-lowering treatment: the patient perspective.

Authors:  Manuela Casula; Elena Tragni; Alberico Luigi Catapano
Journal:  Patient Prefer Adherence       Date:  2012-11-08       Impact factor: 2.711

6.  Implementing the European guidelines for cardiovascular disease prevention in the primary care setting in Cyprus: lessons learned from a health care services study.

Authors:  Theodora Zachariadou; Henri E J H Stoffers; Costas A Christophi; Anastasios Philalithis; Christos Lionis
Journal:  BMC Health Serv Res       Date:  2008-07-16       Impact factor: 2.655

7.  Effectiveness of statins in Medicare-eligible patients and patients < 65 years using clinical practice data.

Authors:  K M Fox; S K Gandhi; R L Ohsfeldt; J W Blasetto; M H Davidson
Journal:  Int J Clin Pract       Date:  2007-10       Impact factor: 2.503

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.